Andere talen Rocket Pharmaceuticals, Inc.

Aandelen

RCKT

US77313F1066

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 31-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
21,32 ^USD	-0,61%		-0,47%	-28,86%

16/05	Transcript : Rocket Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
10/05	ROCKET PHARMACEUTICALS, INC. : UBS bevestigt koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Transcript : Rocket Pharmaceuticals, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM	16/05
ROCKET PHARMACEUTICALS, INC. : UBS toujours positif	10/05
Rocket Pharmaceuticals Presents Positive Data from Lv Hematology Portfolio At the 27Th Annual Meeting of the American Society of Gene and Cell Therapy	10/05
Rocket Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	06/05
Rocket Pharmaceuticals Insider Sold Shares Worth $1,945,785, According to a Recent SEC Filing	16/04
Rocket Pharmaceuticals Insider Sold Shares Worth $308,763, According to a Recent SEC Filing	11/04
Rocket Pharmaceuticals Says European Medicines Agency Accepted Marketing Authorization Application for RP-L102	02/04
ROCKET PHARMACEUTICALS, INC. : Goldman Sachs est neutre sur le titre	02/04
Rocket Pharmaceuticals, Inc. Announces European Medicines Agency Acceptance of RP-L102 Marketing Authorization Application for the Treatment of Fanconi Anemia	02/04
Rocket Pharmaceuticals, Inc. Announces Executive Appointments	26/03
ROCKET PHARMACEUTICALS, INC. : Opinion positive de UBS	01/03
Rocket Pharmaceuticals Q4 Loss Narrows	26/02
Rocket Pharmaceuticals, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	26/02
Rocket Pharmaceuticals Says FDA Extends Review Timeline for Kresladi; Shares Decline	13/02
Rocket Pharmaceuticals, Inc. Announces Update on Fda Review Timeline of Kresladi? (Marnetegragene Autotemcel) for the Treatment of Severe Leukocyte Adhesion Deficiency-I (Lad-I)	13/02
Transcript : Rocket Pharmaceuticals, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 03:45 PM	09/01
Rocket Pharmaceuticals, Inc. Appoints R. Keith Woods as Independent, Non-Executive Director	12/12
Rocket Pharmaceuticals Insider Sold Shares Worth $450,646, According to a Recent SEC Filing	17/11
Rocket Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06/11
ROCKET PHARMACEUTICALS, INC. : Cantor Fitzgerald optimiste sur le dossier	24-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Rocket Pharmaceuticals, Inc.

Aandelen

RCKT

US77313F1066

Andere talen

Filters